Geode Capital Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.4M Buy
2,881,159
+39,481
+1% +$199K ﹤0.01% 2308
2025
Q4
$19.2M Sell
2,841,678
-2,264
-0.1% -$15.9K ﹤0.01% 2020
2025
Q3
$19.9M Buy
2,843,942
+789
+0% +$5.48K ﹤0.01% 2007
2025
Q2
$17.4M Sell
2,843,153
-69,368
-2% -$461K ﹤0.01% 2026
2025
Q1
$22.1M Buy
2,912,521
+133,112
+5% +$1.11M ﹤0.01% 1847
2024
Q4
$26.7M Sell
2,779,409
-14,949
-0.5% -$116K ﹤0.01% 1800
2024
Q3
$16.5M Buy
2,794,358
+44,254
+2% +$293K ﹤0.01% 2081
2024
Q2
$19.1M Buy
2,750,104
+129,138
+5% +$908K ﹤0.01% 1950
2024
Q1
$20.2M Buy
2,620,966
+82,784
+3% +$665K ﹤0.01% 1923
2023
Q4
$22.3M Buy
2,538,182
+109,838
+5% +$804K ﹤0.01% 1844
2023
Q3
$17.7M Buy
2,428,344
+97,067
+4% +$723K ﹤0.01% 1899
2023
Q2
$15.4M Buy
2,331,277
+132,740
+6% +$677K ﹤0.01% 2033
2023
Q1
$7.5M Buy
2,198,537
+98,900
+5% +$383K ﹤0.01% 2434
2022
Q4
$5.84M Buy
2,099,637
+45,626
+2% +$136K ﹤0.01% 2586
2022
Q3
$5.89M Buy
2,054,011
+280,498
+16% +$997K ﹤0.01% 2583
2022
Q2
$6.15M Buy
1,773,513
+127,205
+8% +$498K ﹤0.01% 2585
2022
Q1
$7.75M Sell
1,646,308
-39,806
-2% -$195K ﹤0.01% 2522
2021
Q4
$10.2M Buy
1,686,114
+17,163
+1% +$119K ﹤0.01% 2438
2021
Q3
$10.1M Sell
1,668,951
-78,040
-4% -$880K ﹤0.01% 2444
2021
Q2
$21.9M Buy
1,746,991
+877,045
+101% +$9.5M ﹤0.01% 1899
2021
Q1
$8.96M Sell
869,946
-37,615
-4% -$363K ﹤0.01% 2433
2020
Q4
$8.24M Buy
+907,561
New +$6.53M ﹤0.01% 2294
2018
Q4
Sell
-1,064,908
Closed -$6.58M 4161
2018
Q3
$6.58M Buy
1,064,908
+50,504
+5% +$228K ﹤0.01% 2190
2018
Q2
$6.48M Buy
1,014,404
+12,705
+1% +$90.4K ﹤0.01% 2161
2018
Q1
$6.98M Buy
1,001,699
+64,118
+7% +$747K ﹤0.01% 2025
2017
Q4
$11.8M Sell
937,581
-125,759
-12% -$1.53M ﹤0.01% 1619
2017
Q3
$12.6M Buy
1,063,340
+40,383
+4% +$599K ﹤0.01% 1554
2017
Q2
$15.3M Buy
1,022,957
+55,655
+6% +$743K 0.01% 1394
2017
Q1
$9.22M Buy
967,302
+43,591
+5% +$368K ﹤0.01% 1673
2016
Q4
$8.18M Buy
923,711
+92,983
+11% +$835K ﹤0.01% 1719
2016
Q3
$7.13M Buy
830,728
+16,093
+2% +$127K ﹤0.01% 1719
2016
Q2
$6.5M Buy
814,635
+10,449
+1% +$81.3K ﹤0.01% 1731
2016
Q1
$7.03K Buy
804,186
+56,390
+8% +$469K ﹤0.01% 1631
2015
Q4
$7.01M Buy
747,796
+25,236
+3% +$219K ﹤0.01% 1625
2015
Q3
$6.97M Buy
722,560
+50,910
+8% +$537K ﹤0.01% 1601
2015
Q2
$7.78M Buy
671,650
+37,043
+6% +$381K ﹤0.01% 1596
2015
Q1
$6.6M Buy
634,607
+73,172
+13% +$685K ﹤0.01% 1694
2014
Q4
$6.47M Buy
561,435
+96,233
+21% +$951K ﹤0.01% 1660
2014
Q3
$3.32M Buy
465,202
+3,166
+0.7% +$22.1K ﹤0.01% 2023
2014
Q2
$3.27M Buy
462,036
+36,802
+9% +$215K ﹤0.01% 2073
2014
Q1
$2.61M Buy
425,234
+32,708
+8% +$240K ﹤0.01% 2183
2013
Q4
$3.43M Buy
392,526
+34,461
+10% +$211K ﹤0.01% 1962
2013
Q3
$1.49M Buy
358,065
+12,164
+4% +$67K ﹤0.01% 2348
2013
Q2
$2.44M Buy
+345,901
New +$2.42M ﹤0.01% 1916

Other funds holding MDXG

Geode Capital Management's MDXG Position: Q1 2026 in Review

Geode Capital Management increased its MiMedx Group (MDXG) stake by 1.4% in Q1 2026, buying an estimated $199K and bringing the position to 2,881,159 shares worth $11.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2308.

Geode Capital Management first reported a position in MDXG in Q2 2013 and has held it in 44 quarters since. The position peaked at $26.7M in Q4 2024. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Geode Capital Management held 2,881,159 shares of MiMedx Group worth $11.4M as of Q1 2026.
  • Geode Capital Management bought 39,481 MiMedx Group shares in Q1 2026, an estimated $199K.
  • MiMedx Group made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2308 holding.
  • Geode Capital Management first reported a position in MiMedx Group in Q2 2013 and has held it in 44 quarters since.
  • Geode Capital Management's MiMedx Group position peaked at $26.7M in Q4 2024.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.